DOSSIER · 13F Holders · Q3 2026
BGMS
Cyclacel Pharmaceuticals Inc
10 institutions still hold Cyclacel Pharmaceuticals Inc as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 23254L876·10 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q3 2026
10 institutions reported BGMS in Q3 2026. CITADEL ADVISORS LLC leads at 51.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.